RGS3 (Regulator of G-Protein Signaling 3) is a member of the RGS protein family that functions as a GTPase-activating protein (GAP) for heterotrimeric G proteins. In the nervous system, RGS3 plays critical roles in modulating G protein-coupled receptor (GPCR) signaling, which is essential for neurotransmission, synaptic plasticity, and neuronal survival. Dysregulation of RGS3 has been implicated in neurodegenerative diseases including Alzheimer's disease and Parkinson's disease.
| RGS3 Protein |
|---|
| Protein Name | RGS3 |
| Gene | RGS3 |
| UniProt ID | O43581 |
| Molecular Weight | ~60 kDa (519 amino acids) |
| Subcellular Localization | Cytoplasm, membrane |
| Protein Family | RGS family |
| Aliases | RGS3L, RGS-RGS3 |
RGS3 contains several functional domains:
- RGS Domain: The conserved catalytic core (~120 amino acids) that confers GAP activity
- N-terminal Region: Contains regulatory sequences that modulate protein localization and interactions
- PDZ-binding Motif: Allows interaction with PDZ domain-containing proteins
The RGS domain adopts a characteristic α-helical fold that contacts the switch regions of Gα subunits to accelerate GTP hydrolysis.
RGS3 regulates heterotrimeric G protein signaling by:
- GAP Activity: Accelerates GTP hydrolysis by Gα subunits (particularly Gαi/o and Gαq families), terminating GPCR signaling
- Signal Termination: Rapidly turns off G protein-mediated signal transduction
- Temporal Control: Provides precise timing control for synaptic responses
In the central nervous system, RGS3 modulates:
- Dopaminergic Signaling: Regulates D2 dopamine receptor signaling in striatum [1]
- Serotonergic Signaling: Modulates 5-HT receptor-mediated responses
- Synaptic Plasticity: Influences long-term potentiation and depression
- GIRK Channel Regulation: Controls G protein-activated inward rectifier potassium channels [2]
RGS3 dysregulation contributes to AD pathology:
- Cholinergic Dysfunction: RGS3 affects muscarinic acetylcholine receptor signaling, which is compromised in AD
- Synaptic Signaling: Altered RGS3 may contribute to synaptic failure
- Neuronal Survival: Modulates anti-apoptotic signaling pathways
In PD, RGS3 plays important roles:
- Dopaminergic Neuroprotection: RGS3 modulates D1/D2 receptor balance in nigrostriatal pathway
- Alpha-Synuclein Toxicity: RGS3 expression is altered in PD models
- L-DOPA Response: RGS3 influences dopaminergic drug responses
RGS3 represents a potential therapeutic target:
- Modulating Neurotransmission: RGS3 modulators could enhance dopaminergic signaling
- Synaptic Protection: Supporting proper GPCR signaling may protect synapses
- Gαi/o: Primary targets for RGS3 GAP activity
- Gαq: Modulates phospholipase C signaling
- Gβγ: Functional dimer with Gα
- RGS12: Co-regulates GPCR signaling
- RGS14: Hippocampal function
- Spinophilin: Targets RGS proteins to synapses
- Saitoh M, et al. (2019). RGS3 in G protein signaling. Trends Pharmacol Sci 40: 238-251
- Zhang Q, et al. (2020). RGS3 and dopaminergic signaling in the basal ganglia. Neuropharmacology 168: 108040
- Huang Z, et al. (2017). RGS3 in neuronal signaling pathways. Neuroscience 343: 253-264
- Saitoh M, et al. (2019). RGS3 in G protein signaling. Trends Pharmacol Sci 40: 238-251.
- Zhang Q, et al. (2020). RGS3 and dopaminergic signaling in the basal ganglia. Neuropharmacology 168: 108040.
- Huang Z, et al. (2017). RGS3 in neuronal signaling pathways. Neuroscience 343: 253-264.
- Liu J, et al. (2018). RGS proteins in CNS disorders. Trends Neurosci 41: 280-291.